Newly formed life sciences law firm Lawford Davies & Co brings together expert lawyers to provide a more complete understanding of legal advice to the sector.
York, 1 April 2023. – James Lawford Davies and Nils Hoppe have joined up to create an innovative new advisory offering, serving the needs of the life sciences sector. Lawford Davies & Co will combine specialist legal advice with regulatory, litigation and ethics expertise to provide a complete and integrated picture of requirements to clients.
The new offering is the combination of James Lawford Davies, a solicitor with over 20 years’ experience in the life sciences sector, and Professor Nils Hoppe, a leading academic in the field of life sciences law and bioethics. They are teaming up with colleagues from different jurisdictions to deliver bespoke, cross-border, and multi-disciplinary advice to clients.
“I am very much looking forward to offering a complete perspective on both the legal and the ethical aspects of cutting-edge life sciences research and translation”, said Professor Nils Hoppe. “Clients in our field have long told us of the need to dovetail these important aspects into more comprehensive advice.”
“It has become clear that in very specialised areas of law, such as this one, clients are in need of lawyers who understand the scientific process and culture. We believe that we are addressing a critical unmet need”, added James Lawford Davies.
Lawford Davies & Co opens its doors on 1 April 2023 and will offer its services both in the UK, with its main offices in York Science Park, as well as in Europe, through offices in Hannover, Germany.
About Lawford Davies & Co: Lawford Davies & Co is a life sciences law firm based in York, UK, with additional offices in Hannover, Germany. The firm specialises in advising on tissue- and cell-based research and therapy, including IVF and embryo research, genomics, medical devices, clinical trials and innovative biomedical research governance.
About James: James Lawford Davies is a solicitor with more than 20 years’ experience in life sciences law. James advises a large number of clinics, hospitals, universities and researchers licensed by the Human Fertilisation and Embryology Authority (HFEA), the Human Tissue Authority (HTA) and the Care Quality Commission (CQC). He has been involved in most of the leading cases relating to IVF, embryo and stem cell research. He also advises on cell and gene therapies, and on the regulation of medical devices and IVD’s.
James is an experienced litigator and has been involved in cases at every level in the UK courts. Much of his work concerns the judicial review of regulatory bodies, and cases arising as a result of regulatory action.
About Nils: Nils Hoppe is a professor of ethics and law in the life sciences. He has previously advised cross-border clinical trials with innovative structures, large-scale biobanks, and numerous life sciences startups in the regenerative medicine sector. Nils has particular expertise in property law aspects in science and technology. He is also a member of a number of governmental and corporate advisory boards addressing innovative health technologies.
Contact: Nils Hoppe
Lawford Davies & Co
The Catalyst / York Science Park
Baird Lane, York YO10 5GA
W: www.lawforddavies.com / E: nils.hoppe@lawforddavies.com / M: +44 7958 166664
English (UK) 
Deutsch